Download now





    Put targeted AI agents to work on the slowest parts of your trials, so your teams move faster while safety and compliance stay rock solid.

    Clinical Trials Are Too Important to Move at Yesterday’s Speed

    Clinical trials are high-stakes, expensive, and still far too slow. Many studies take 8+ years and billions of dollars to complete, while regulators tighten expectations and patients wait for therapies and devices that could change their lives.

    Yet trial teams are stuck wrestling with:

    • Paper-heavy compliance checks and manual TMF review
    • Disconnected CTMS, EDC, IRT, and PV systems
    • Late safety insights that trigger last-minute protocol changes
    • Reporting cycles that drag on for weeks or months 

    This white paper shows how sharp, specialized AI agents can attack these bottlenecks inside your existing ecosystem, so you speed up trials without cutting a single corner on safety or compliance. 

    AI Agents: Targeted Help Where Trials Break Down

    Instead of “one giant platform,” B EYE’s approach uses lightweight, specialized AI agents that plug into your current ecosystem and fix specific pain points without forcing you to rip and replace your existing platforms: 

    • DocsReviewer – automates QC for protocols, ICFs, and TMF content to streamline regulatory readiness. 
    • DrugSafe AI – continuously scans safety data to catch signals early and reduce late-stage surprises. 
    • ReportGenie – accelerates DSURs, CSRs, and executive reporting from weeks to days.
    • ChainQuery – gives trial managers instant, natural-language access to data across CTMS, EDC, and IRT. 
    • Healthcare Advisor – supports trial sites with real-time clinical decision support and patient engagement. 

    The result: faster, safer, more compliant trials that move therapies and devices to patients sooner.  

    What This Whitepaper Will Help You Do

    Use this guide to build a practical, board-ready vision for AI in clinical operations. You’ll learn how to:  

    • Understand the clinical trial landscape in 2026 and why AI is shifting from side project to standard practice in clinical trials. 
    • Identify exactly where trials break down — from protocol burden to slow reporting — and map them to AI agent solutions. 
    • Quantify the ROI and business case for AI-powered trials, including how 15–20% timeline reductions translate into millions in value.  
    • Design a phased implementation roadmap that starts with quick wins and scales without a “big bang” IT overhaul.

    If you’re being asked to “do more with less” in the cloud — this is for you.

    Who It’s For

    This white paper is tailored for life sciences and MedTech leaders responsible for clinical, safety, and regulatory outcomes, including:  

    • Heads of Clinical Development & Clinical Operations
    • VPs / Directors of R&D, Medical Affairs & PV
    • Chief Medical Officers & Chief Scientific Officers
    • Regulatory Affairs & Quality Leaders
    • Clinical Data Management & Biostatistics Leaders
    • IT, Digital, and Innovation leaders supporting clinical platforms 
    • MedTech and pharma executives driving time-to-market and risk reduction

    If you’re under pressure to accelerate trials and protect compliance at the same time, this is for you.

    Inside, You’ll Get

    A concise, strategic roadmap to AI-powered clinical trials, including:

    • The clinical trial reality in 2026
    • Where trials break down and how AI fixes it
    • AI agents in action: real use cases in MedTech device and Pharma & pharmacovigilance trials
    • ROI & the business case for AI in trials
    • Implementation roadmap: from pilot to scale

    Download the Whitepaper

    Fill in the form to get instant access to the white paper. 

    You’ll receive: 

    • A downloadable PDF to share with clinical, PV, regulatory, and digital teams 
    • Concrete examples of AI agents applied to real clinical scenarios 
    • A practical roadmap to make your next wave of trials faster, safer, and more compliant 

    Meet the Authors

    Teo Parashkevov

    Co-Author

    Teo Parashkevov designs and delivers production-grade AI and GenAI solutions, combining deep hands-on machine learning expertise with technical leadership as an AI Team Lead. He specializes in LLM-based systems, model orchestration, and end-to-end deployment, building scalable, reliable, and enterprise-ready AI architectures that turn advanced models into measurable business outcomes.

    Marta Teneva

    Editor-in-Chief

    Marta Teneva, Head of Content at B EYE, specializes in creating insightful, research-driven publications on BI, data analytics, and AI, co-authoring eBooks and ensuring the highest quality in every piece.

    Download now